AD-CON (n = 20) | AD-LSP (n = 20) | AD-MSP (n = 20) | AD-SSP (n = 20) | Non-AD-CON (n = 20) | |
---|---|---|---|---|---|
Serum glucose at basal state (mM) | 7.1 ± 0.8 | 6.9 ± 0.7 | 7.1 ± 0.7 | 7.0 ± 1.0 | 7.0 ± 0.6 |
Serum insulin (ng/mL) | 1.37 ± 0.17a | 1.13 ± 0.15b | 1.07 ± 0.16b | 1.05 ± 0.14b | 1.09 ± 0.15b |
HOMA-IR | 12.6 ± 2.5a | 9.4 ± 2.1b | 9.1 ± 1.9b | 8.8 ± 1.9b | 9.2 ± 2.1b |
First phase of insulin (0–10 min; ng/mL) | 2.25 ± 0.35 | 2.18 ± 0.32 | 2.26 ± 0.33 | 2.44 ± 0.34 | 2.51 ± 0.37 |
Second phase of insulin (60–120 min; ng/mL) | 2.66 ± 0.38a | 2.42 ± 0.40ab | 2.34 ± 0.34b | 2.36 ± 0.32b | 2.32 ± 0.34b |
AUC of first phase of insulin (0–10 min; ng/mL*min) | 26.3 ± 3.8 | 25.8 ± 3.5 | 26.7 ± 3.6 | 29.1 ± 3.6 | 30.0 ± 4.2 |
AUC of second phase of insulin (30–120 min; ng/mL*min) | 246 ± 33a | 225 ± 31ab | 215 ± 29b | 217 ± 27b | 212 ± 28b |
Glucose infusion rate (mg/kg bw/min) | 8.6 ± 1.5c | 11.6 ± 1.8b | 12.8 ± 2.0ab | 13.2 ± 2.1a | 13.4 ± 1.9a |
Insulin sensitivity at hyperglycemic state (μmol glucose · min−1 · 100 g−1 per μmol insulin/L) | 3.2 ± 0.6c | 4.8 ± 0.7b | 5.5 ± 0.8a | 5.6 ± 0.8a | 5.8 ± 0.8a |